{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:23:24Z","timestamp":1756383804249,"version":"3.41.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0185449","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T17:39:28Z","timestamp":1507138768000},"page":"e0185449","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vitamin D and methylarginines in chronic kidney disease (CKD)"],"prefix":"10.1371","volume":"12","author":[{"given":"Claudia","family":"Torino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Pizzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Cutrupi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1996","authenticated-orcid":true,"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phrs.2009.07.001","article-title":"Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality\u2014An update on patient populations with a wide range of cardiovascular risk","volume":"60","author":"RH B\u00f6ger","year":"2009","journal-title":"Pharmacol Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrneph.2011.31","article-title":"The role of asymmetric and symmetric dimethylarginines in renal disease","volume":"7","author":"E Schwedhelm","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(03)00007-1","article-title":"Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer\u2019s disease","volume":"24","author":"ML Selley","year":"2003","journal-title":"Neurobiol Aging"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"MC St\u00fchlinger","year":"2002","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1210\/jc.2002-020905","article-title":"Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients","volume":"87","author":"C Hermenegildo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/01.CIR.0000091083.61609.DF","article-title":"Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine","volume":"108","author":"DP Holden","year":"2003","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1191\/1358863x02vm429ra","article-title":"The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function","volume":"7","author":"R Maas","year":"2002","journal-title":"Vasc Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1681\/ASN.2007121377","article-title":"A bench to bedside view of uremic toxins","volume":"19","author":"R Vanholder","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02351006","article-title":"Mechanotransduction of bone cells in vitro: Mechanobiology of bone tissue","author":"M Mullender","year":"2004","journal-title":"Medical and Biological Engineering and Computing"},{"key":"ref10","first-page":"224","article-title":"Effect of age on bone mineral density and the serum concentration of endogenous nitric oxide synthase inhibitors in rats","volume":"52","author":"R Lu","year":"2002","journal-title":"Comp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1046\/j.1523-1755.2001.00011.x","article-title":"Effect of asymmetric dimethylarginine on osteoblastic differentiation","volume":"60","author":"ZS Xiao","year":"2001","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.diabet.2016.05.002","article-title":"Elevated parathyroid hormone predicts high asymmetric dimethylarginine (ADMA) concentrations in obese diabetic patients","volume":"42","author":"AT Amarasekera","year":"2016","journal-title":"Diabetes Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.amjmed.2009.09.024","article-title":"Does Vitamin D Modulate Asymmetric Dimethylarginine and C-Reactive Protein Concentrations?","volume":"123","author":"DT Ngo","year":"2010","journal-title":"Am J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2017.05.002","article-title":"Association between vitamin D status and asymmetric dimethylarginine (ADMA) concentration in the Korean elderly population","volume":"102","author":"HR Choi","year":"2017","journal-title":"Maturitas"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.20452\/pamw.917","article-title":"Effects of vitamin D3 on selected biochemical parameters of nutritional status, inflammation, and cardiovascular disease in patients undergoing long-term hemodialysis","volume":"120","author":"A Bednarek-Skublewska","year":"2010","journal-title":"Pol Arch Med Wewn"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ekir.2016.10.002","article-title":"Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol","author":"E Oliva-Damaso","year":"2017","journal-title":"Kidney Int Reports"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"gfw439","DOI":"10.1093\/ndt\/gfw439","article-title":"Do we still need cross-sectional studies in Nephrology? Yes we do!","volume":"32","author":"G Tripepi","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"ref18","article-title":"Paricalcitol and Endothelial Function in Chronic Kidney Disease Trial","author":"C Zoccali","year":"2014","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"AS Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1515\/CCLM.2004.257","article-title":"Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay","volume":"42","author":"F Schulze","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"ref21","unstructured":"DLD-diagnostica. SDMA-Elisa [Internet]."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ki.2008.645","article-title":"The effect of joint exposures: examining the presence of interaction","volume":"75","author":"R de Mutsert","year":"2009","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"C Zoccali","year":"2001","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.atherosclerosis.2009.05.011","article-title":"Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study","volume":"207","author":"F Aucella","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1523-1755.2002.00437.x","article-title":"Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients","volume":"62","author":"C Zoccali","year":"2002","journal-title":"Kidney Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study","volume":"16","author":"D Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"P Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1253\/jcj.65.775","article-title":"Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension","volume":"65","author":"a Ito","year":"2001","journal-title":"Jpn Circ J"},{"key":"ref29","first-page":"1462","article-title":"Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension","volume":"61","author":"C Delles","year":"2002","journal-title":"Kidney Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1161\/hc5001.100621","article-title":"Impact of hyperthyroidism and its correction on vascular reactivity in humans","volume":"104","author":"R Napoli","year":"2001","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1053\/meta.2002.33349","article-title":"Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes","volume":"51","author":"T Asagami","year":"2002","journal-title":"Metabolism"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"MC Stuhlinger","year":"2002","journal-title":"J Am Med Assoc"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-030584","article-title":"Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women","volume":"88","author":"MS Post","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2005.09.029","article-title":"The determinants of endothelial dysfunction in CKD: Oxidative stress and asymmetric dimethylarginine","volume":"47","author":"MI Yilmaz","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000441364","article-title":"Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial","volume":"42","author":"K Lundwall","year":"2015","journal-title":"Am J Nephrol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.amjmed.2009.09.024","article-title":"Does Vitamin D Modulate Asymmetric Dimethylarginine and C-Reactive Protein Concentrations?","volume":"123","author":"DT Ngo","year":"2010","journal-title":"Am J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2215\/CJN.10030911","article-title":"Randomized Trial Assessing the Effects of Ergocalciferol Administration on Circulating FGF23","volume":"7","author":"S-AM Burnett-Bowie","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1159\/000312871","article-title":"Selection bias and information bias in clinical research","volume":"115","author":"G Tripepi","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"M Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/pds.3349","article-title":"Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis","volume":"21","author":"JE Miller","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"R Thadhani","year":"2012","journal-title":"JAMA"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0185449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:27:47Z","timestamp":1750897667000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0185449"}},"subtitle":[],"editor":[{"given":"Mario","family":"Cozzolino","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0185449","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,10,4]]}}}